Latest News

"A 30% discrepancy in results." During his talk at EACVI, Professor James Moon shared the moment he realised the tools doctors relied on simply weren't good enough. For a clinician dealing with heart failure, that ambiguity was unacceptable. This is the story of how a concern for "metrology", the science of measurement, turned into a mission to exceed human performance. From scanning patients o....

We are delighted to announce a major strategic partnership between MyCardium AI and Optum | Change Healthcare Enterprise Imaging Healthcare, one of the largest and most trusted enterprise imaging and PACS integration providers in the world. This collaboration represents a significant milestone for MyCardium AI and marks the beginning of a new era in cardiovascular imaging, where intelligent a....

MyCardium AI has been recognised among the UK’s top 16 AI startups to watch, following its inclusion in Sifted’s latest feature highlighting ventures shaping the future of artificial intelligence across multiple industries. The article, based on insights from leading venture capital firms including Amadeus Capital Partners, Baltic Ventures, Ada Ventures and others, identifies emerging....

London, UK - October 2025 MyCardium AI is proud to announce its role as the Core Laboratory in the recently published NEJM study: Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction. The trial investigated whether percutaneous coronary intervention (PCI) of nonculprit lesions should be performed immediately or deferred in patients with myocardial infarction. This study has signi....

MyCardium AI has been featured in the Financial Times article, “AI start-ups make big gains in healthcare.” The feature highlights a new generation of innovators using artificial intelligence to accelerate clinical decision-making and improve patient outcomes across global healthcare systems. As a spin-out from University College London (UCL), one of the world’s leading centres ....